Mitral Adjustable Annuloplasty Ring Feasibility and Safety Study

Inclusion Criteria: * Males or females aged greater or equal to 18 to less than or equal to age 75. * Patients with indications to undergo mitral valve repair consistent with ACC/AHA recommendations; including greater or equal to 2+ regurgitation by pre-operative TEE or TTE assessment. * Candidate for cardiopulmonary bypass. * A Left Ventricular Ejection Fraction greater or equal to 40%. * Able and willing to comply with all study requirements, including the required study follow-up visits. * Able and willing to five consent and follow study instructions. * Female patients of childbearing potential (not surgically sterilized or more than one year postmenopausal), with a negative pregnancy test (serum beta-hCG) within 24 hours prior to mitral valve surgery. Exclusion Criteria: * Any previous cardiac surgery. * Any interventional cardiology procedure within six months prior to study to include all patients that have had a drug eluting stent (DES) implanted within 6 months. * Evidence of an acute Myocardial Infarction (MI) within 7 days of the intended treatment with the investigational device. * Prior mitral valve surgery or valvuloplasty or currently implanted prosthetic valve. * Restricted mobility of the mitral apparatus that results in a valvular area less than 3.0 cm2. * Recent or evolving bacterial endocarditis or patients under current antibiotic therapy. * Patients with ICD's. * Any angiographic or clinical evidence that the investigator feels would place the patient…